Results 181 to 190 of about 322,522 (245)

Interleukin‐18 levels are associated with disease course in patients with Still's disease treated with IL‐1 inhibitors

Arthritis &Rheumatology, Accepted Article.
Objective To evaluate the prognostic utility of circulating Interleukin‐18 (IL‐18) levels in predicting disease activity, macrophage activation syndrome (MAS), and disease course in Still's disease (SD) patients receiving first‐line IL‐1 inhibitors (IL‐1i).
Matteo Trevisan, Manuela Pardeo, Ivan Caiello, Claudia Bracaglia, Arianna de Matteis, Valentina Matteo, Elena Loricchio, Fabrizio De Benedetti, Giusi Prencipe   +8 more
wiley   +1 more source

Recommendations for Transitioning Young People with Primary Immunodeficiency Disorders and Autoinflammatory Diseases to Adult Care. [PDF]

J Clin Immunol
Israni M, Alderson E, Mahlaoui N, Obici L, Rossi-Semerano L, Lachmann H, Avramovič MZ, Guffroy A, Dalm V, Rimmer R, Solis L, Villar C, Gennery AR, Skeffington S, Nordin J, Warnatz K, Korganow AS, Antón J, Cattalini M, Berg S, Soler-Palacin P, Campbell M, Burns SO, ESID Clinical Working Party, ERN RITA Transition Working Group Consortium.   +24 more
europepmc   +2 more sources

Genetic causes of primary immunodeficiency in the Jordanian population. [PDF]

Biomed Rep
Obeidat L, Abu-Halaweh M, Alzyoud R, Albsoul E, Zaravinos A.   +4 more
europepmc   +1 more source

The impact of viral evolution and frequency of variant epitopes on primary and memory human immunodeficiency virus type 1-specific CD8+ T cell responses

, 2013
Nada M. Melhem, Kellie N. Smith, Xiao-Li Huang, Bonnie A. Colleton, Weimin Jiang, Robbie B. Mailliard, James I. Mullins, Charles R. Rinaldo   +7 more
openalex   +1 more source

Transplant Outcomes for Primary Immunodeficiencies in a Tertiary Center 1995-2015 [PDF]

, 2016
Nikita Raje, Duha Al‐Zubeidi, Barbara Chignola   +2 more
openalex   +1 more source

Risk factors for relapse in ANCA‐associated vasculitis among patients with relapse after induction of remission with rituximab

Arthritis &Rheumatology, Accepted Article.
Objective To determine risk factors for relapse of ANCA‐associated vasculitis (AAV) after re‐induction of remission with rituximab and discontinuation of maintenance therapy. Methods This is a post‐hoc analysis of the RITAZAREM clinical trial. Patients 15 years or older with AAV and a positive test for anti‐proteinase‐3 (PR3‐) or anti‐myeloperoxidase ...
Ellen Romich, Joshua F. Baker, Thomas R. Riley IV, Ian Green, Rennie L. Rhee, Carol A. McAlear, Ulrich Specks, Rona M. Smith, David R. Jayne, Peter A. Merkel, for the RITAZAREM Investigators   +10 more
wiley   +1 more source

Corrigendum to “Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs)”

Journal of the Formosan Medical Association, 2012
Wen-I. Lee, Jing-Long Huang, Kuo-Wei Yeh, Tang-Her Jaing, Tzou-Yien Lin, Yhu-Chering Huang, Cheng-Hsun Chiu   +6 more
doaj   +1 more source

Primary Immunodeficiency: Specific antibody deficiency with normal IgG. [PDF]

Allergy Asthma Proc
Hatcher VR, Alix VC, Hellu TS, Schuldt MM.   +3 more
europepmc   +1 more source

Psychoactive prescription drug use and misuse in patients on opioid agonist treatment

British Journal of Clinical Pharmacology, EarlyView.
Aims To identify the patterns and trends in prescription drug use and misuse in patients on opioid agonist treatment. Methods We used data from the OPPIDUM programme, which collects data from patients attending substance abuse treatment facilities. Data collected include use of psychoactive prescription drugs in the past week.
Thomas Soeiro, Clémence Lacroix, Élisabeth Jouve, Élisabeth Frauger, Maryse Lapeyre‐Mestre, Joëlle Micallef   +5 more
wiley   +1 more source

Primary immunodeficiency as a cause of immune-mediated kidney diseases. [PDF]

Nephrol Dial Transplant
Zhang C, Liang D, Liu Z.
europepmc   +1 more source